Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly ...
Inari Medical chief medical officer Tom Tu said: “There is a real clinical need to address chronic thrombi and decrease the ...
Inari Medical — now part of Stryker — announced that it launched its Artix thrombectomy system for arterial thrombectomies.
Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix ...
Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System. Purpose-built for the distinct needs of the peripheral ...
"There is a real clinical need to address chronic thrombi and decrease the risk of clot migration. Artix will raise the bar of effective arterial thrombectomy," said Tom Tu, MD, Chief Medical ...
"There is a real clinical need to address chronic thrombi and decrease the risk of clot migration. Artix will raise the bar of effective arterial thrombectomy," said Tom Tu, MD, Chief Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results